v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Research and development (“R&D”) expenses, net $ 3,824 $ 3,717 $ 9,494 $ 7,246
Amortization of intangible assets 380 380 759 759
General and administrative expenses 3,098 2,297 5,591 4,355
Operating loss 7,302 6,394 15,844 12,360
Financial expenses (income), net 31 (188) (112) (253)
Loss before tax 7,333 6,206 15,732 12,107
Tax expenses 3 6  
Net Loss $ 7,336 $ 6,206 $ 15,738 $ 12,107
Basic and diluted loss per share of Common Stock (in Dollars per share) $ 0.30 $ 0.27 $ 0.65 $ 0.53
Weighted average number of shares of Common Stock outstanding, basic and diluted (in Shares) 24,320,259 22,969,075 24,134,065 22,944,482

Source